Weaning oxygen in infants with bronchopulmonary dysplasia.
Paediatr Respir Rev
; 39: 82-89, 2021 Sep.
Article
en En
| MEDLINE
| ID: mdl-33309219
Bronchopulmonary dysplasia (BPD) is a form of chronic lung disease commonly seen in preterm infants as the sequelae following respiratory distress syndrome. The management of evolving BPD aims to minimise lung injury and prevent the impact of hypoxia and hyperoxia. Proposed morbidities include respiratory instability, pulmonary hypertension, suboptimal growth, altered cerebral oxygenation and long-term neurodevelopmental impairment. The ongoing management and associated morbidity present a significant burden for carers and healthcare systems. Long-term oxygen therapy may be required for variable duration, though there is a lack of consensus and wide variation in practise when weaning supplemental oxygen. Furthermore, a shift in care towards earlier discharge and community care underlines the importance of a structured discharge and weaning process that eliminates the potential risks associated with hypoxia and hyperoxia. This review article describes recent evidence outlining oxygen saturation reference ranges in young infants, on which structured guidance can be based.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Displasia Broncopulmonar
Tipo de estudio:
Guideline
Límite:
Humans
/
Infant
/
Newborn
Idioma:
En
Revista:
Paediatr Respir Rev
Asunto de la revista:
PEDIATRIA
Año:
2021
Tipo del documento:
Article
Pais de publicación:
Reino Unido